Bausch Health

Bausch Health Companies Inc. is a multinational specialty pharmaceutical company based in Laval, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health, and neurology. Bausch Health owns Bausch & Lomb, a supplier of eye health products.
Bausch Health stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Bausch Health balance sheet

Report period2018 2019 2020 2021 20222023
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Bausch Health cash flows

Report period2018 2019 2020 2021 20222023
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Bausch Health multipliers

Report period2018 2019 2020 2021 20222023
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

Bausch Health profitability

Report period2018 2019 2020 2021 20222023
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Bausch Health assets
Bausch Health cash flows

Bausch Health shares

TickerNameTypeNominal valueISINPrice
BHC:USBausch HealthCommon share-CA0717341071$8.69
Bausch Health news
11.05.2022
Bausch Health's GAAP loss for 3 months of 2022 was $66 million, down 9.2 times from $607 million in the previous year. Revenue decreased by 5.4% to $1.918 billion from $2.027 billion a year earlier.
Source: {source} pictogram ir.bauschhealth.com
Pictogram next
23.02.2022
Bausch Health's GAAP loss for 2021 was $937 million, up 67.6% from $559 million in the previous year. Revenue increased 4.9% to $8.424 billion from $8.027 billion a year earlier.
Source: {source} pictogram bauschhealth.com
Pictogram next
02.11.2021
Bausch Health's GAAP loss for 9M 2021 was $1.009 billion, up 2.5 times from $0.407 billion in the previous year. Revenues increased 7.3% to $6.238 billion from $5.814 billion a year earlier.
Source: {source} pictogram ir.bauschhealth.com
Pictogram next
03.08.2021
Bausch Health's GAAP loss for 6 months 2021 was $1.2 billion, up 2.5 times from $0.477 billion in the previous year. Revenues increased 12.3% to $4.127 billion from $3.676 billion a year earlier.
Source: {source} pictogram bauschhealth.com
Pictogram next
All Bausch Health news
General information
Company nameBausch Health
Tags#pharmacy
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business address2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Mailing address2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Websitewww.bauschhealth.com